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- 
objectives. This study W.IS designed to compare lhe long-term 
eliuical and nngiographd~ elects of successful directiuna9 atherec- 
tomy und stem implan!.stfon and to examine wbether eestenosis is 
related to the mecban’sm of lumen improvement as we91 as the 
extent of 9mm gain. 
Backgrozmd. Directional atherectomy and coronary steut im- 
p93ntatiort hove tweu sLown to arhi~e B more optima9 immediate 
result that may lead to 3 mare f3vorable long-term angiographic 
outcome and fewer target vessel revascularizations than does 
angioplasty, 99owever, it remains to be determined whether one of 
tbe devices used In these interventions provides consistentfy better 
results than the other. 
Mthads. To allow meanin 9 comparisons, a prospectively 
collected series of 117 patients successfu99y treated with atherec- 
tomy were individua99y matched with a prospectively coflected 
series of 999 patients successfully treated with stem implantation. 
Matching for baseline characteristics identified patients with 
ideutical lesion kocation and lesiou severity, and immedirte and 
late angiographic and cfinica9 outcome were compared. To eva9u- 
ate the possibility of 3 procedure effect on restenosis, patients 
were further matched for both immediate angiograpbic outcome 
and baseline characteristics, providing 150 nmtched patients for 
compar9son. As cotdhmatory analysis, mu9ti~ari3te models were 
constructed to predict late lumen diameter. 
Results. Matching resulted in two comparable groups with 
equivalent baseline clinicat and stenosis ebaracteristics (3 = 117 
pairs). Atherestomy led to a smaller immediate gain than stertiug 
and, because late loss was similar in both groops, stentbrg 
resulted in a larger tate lumen (9.96 2 Q.59 vs. l&i zk 0.55 mm, 
p c t9AM9S). When patients were m3tched for immediate gain and 
basefine cbararteristics (n = 95 pairs>, tumen loss was more 
pronounred after atherectomy, and thus the mbtimal lumen 
diameter at follow-up differed signibcantly between the two groups 
(1.66 f 0.53 vs. 1.91) 2 0.47 mm, p = tMt94). This beneticial 
angiographic effect of stentiq was accompanied by a reduced 
need for tqte3t interventions. Multivariate ana9ysis contirmed the 
independent effect of the interventional device used, whereby less 
loss aod greater lumen diameter at fo99ow-up were predicted for 
stem imp9antatiou than for atherectomy* 
Conchions. Suceessftd stent impbntation provided 3 more 
favorabte long-term angiogtaphic outcome and 9uwer n#es of 
restenosis and need for Wget lesion rcvascutarization than did 
at~er~tomy. Ibis favorab9e effect ofstenting not on9y is relrted to 
a larger immediate @I, hut alsn seems to attenuate late 9umen 
IOSS. 
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were compared with conventional balloon angioplasty for their 
ability to reduce restenosis (10-13). Although both techniques 
achieved a greater lumen gain than did balloon angiopiasty, 
only stenting reduced the rcstenosis rate s~gy~~~c~~nt~y (I 2,13). 
Whereas these trials showed a comparable lumen gain after 
~~therecto~~y and stenting, wc recognized that the tli@eren~e in 
lumen renarrowing after atllere~torny and stenting may relate 
to either t!~e extent or the mechanism (dcbvking versus 
s&folding) of lumen improvement. 
In this study we comparatively evaluated successful direc- 
tional atherectomy and stent rmplantation in a prospectively 
collected series of 234 patienls by using the previously vali- 
dated matching methodology. By matching for both immediate 
angiographic outcome and baseline characteristics, we cs- 
tended our observatiotls and tested the hypothesis that each 
interventional device has unique propertics with respect to 
lumen renarrowing that are independenr of ciinicai, engio- 
graphic OI procedural characteristics. 
i&k&hOds: 
Mere&my group. From September 1989 through March 
1994, 208 patients underwent 214 directional atherectomy 
procedures for native coronary or bypass graft lesions. Of 
these, 150 consecutive patients (who underwent 157 successful 
procedutrcsj have had a &month follow-up angiographic study 
(ar~g~o~~ar~h~c followup rate 90%). For the purpose of this 
study, the late outcome of E L ~ a h~:ectom? was compared with that -r
of stenting for consecutive native primary lesions. Therefore, 
patients with restenotic lesions and patients with a subacute 
coronary occlusion of ~24 h duration were excluded. Of the 
153 patients, 3 were treated for a lesion in a venous bypass 
graft and 13 undeirwent atherectomy for 18 restenotic lesions 
after previous angioplasty. Thus, 134 patients who underwent 
136 succcssfuf atherectoml procedures for native primary 
coronary arter: disease wer2 eligible for matching. 
inflation pressure was increasecl to maximally 45 psi. The 
driving motor was activated and the rotating cutter was slowly 
advanccd to cut and ccallcct the protruding atherosclerotic 
k&m in the collecting chamber Iocatecl at the tip of the 
caehcter. After every pass the ballnon was d&ted and either 
removed or repositioned. A 6F athcrectomy device was used in 
34% of patients and a 7F dcvkc in 66%. .Adjunctive balloon 
dilation was performed in 23%. Although an optimal angio- 
graphic result was sought for each lesion treated, the proce- 
dure was considered angiographically successful when the 
residual diameter stenosis was <SO% after tissue retrieval. 
This classic definition of success hould be viewed in historical 
perspective; currently a lumen gain of -50.7 mm or a 
postathercctomy diameter stenosis ~20% may be deemed 
necessary before a procedure is considered successful, as 
recently observed in retrospective analyses (2) and as delined 
in the ongoing atherectomy trials (Balloon vs. Optimal 
Atherectomy Trial [BOAT], Optimal Atherectomy Restenosis 
Study [OARS], European Carvediiol Restenosis trial 
[EUROCARE]). Such a resuit was reached in 22% of cases. 
Stenting was performed by the femoral approach and the stent 
was delivered by inflation of the balloon that cc?atained the 
crimped stent. The following Palmaz-Schatz stents were im- 
planted: 3.0 mm (46%), 3.5 mm (39%) and 4.0 mm (15%). 
Additional intrsstent balloon dilation was performed in 27 
patients (23%). Anticoagulation during and after stent implan- 
tation was given according to the protocol and contained 
heparin, dextran, dipyridamole, aspirin and warfarin for 3 
months. Patients were monitored as described earlier (7- 
9,12,13). 
Quantitative coronary angiography, Quantitative analysis 
of the coronaq segments was performed with the computer- 
based Coronary Angiography Analysis System (CAASj, which 
has been previously validated and des:ribed En detail 
(X,22,14,15). In particular, ac,:uracy and precision measure- 
ments for in vivo phantom ileasurements are 0.09 and 0.23 
(15). In essence, boundaries of a selected coronary artery 
segment are detected automatically from optically magnified 
and video-digitized regions of interest (~512 x 512 pixels) of a 
tine frame. The absolute diameter of the stenosis in mm is 
determined by using the guiding carheter as a scaling device for 
calibration. The exlexnal diameter of each individual catheter 
is measured by a precision micrometer with a tolerance of 
0.1)01 mm. Correction for pincushion dktortiun is performed. 
Computer estimation of the original dimension of the artery at 
the site of the obstruction proG.!es an inti;rpnirttc;.l refe~~nee 
diamakr. All other variabks (q, ~rn~~~e~l~lt~ gain, late lo@ 
arc ttm ciliAate& 
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artery were identiCed according to the deWions of the Ameri- 
can Heart Association (17). Finally, Polaroid photographs were 
taken of the video image with the detected contours superim- 
posed to ensure that the analyses were performed on the same 
coronary segments. Intracoronary isosorbidc dinitrate (1 to 
3 mg) was given before and after intervention. Administration 
of intracoronary nitrates was recommended t&ore Mow-up 
angiography. 
Matching process. The process of matching for clinical and 
angiographic characteristics (see Appendix) has been previ- 
ously described (7,8,15). Clinical factors such as gender, dia- 
betes, hypercholesterolemia (18) and nonexertional angina 
were taken into account. The coronary artery tree was subdi- 
vided into 15 segments according to American Heart Associ- 
ation guidelines and the lesions were individually matched 
according to stenosis location and reference diameter and 
minimal lumen diameter. The principles of matching by quan- 
titative angiography are threefold: 1) The angiographic dimen- 
sions of matched lesions are assumed to be ‘“identical,” 2) tile 
observed difference between the two “identical:’ lesions must 
be within the range of the reproducibility of the CAAS analysis 
(0.1 mm [ =I SD]), and 3) the reference diameter of the lesions 
to be matched is selected within a range of 20.3 mm (=3 SD) 
(8,14,16). Clinical factors such as gender, diabetes, bypercho- 
lesterolemia and nonexertional angina were taken into ac- 
count. The automated matching program identified 117 pro- 
spectively collected patients with 117 coronary artery lesions 
treated scccessfully with atherectomy who could be individu- 
ally matched with 117 prospectively collected consecutive 
patients treated successfully with stenting (diameter stenosis 
<50% on visnal inspection). The remaining patients (l3%) of 
the atherectonly cohort could not be matched because no 
identical patient with stenting was found according to the 
prespecified mat,*hing criteria. Tbe clinical and angiographic 
details of the nvo groups are given in Table 1. 
To extend our observations and to test the hypothesis that 
each interventional device has unique properties with respect 
to lumen renarrowing that are independc~lt of vessel size and 
lesion severity and lumen gain, matchi~lg LX immediate pro- 
cedural result as well as baseline characteristics yi&ded 1% 
matched patients. 
LAD 
10 
RCA 
Nonexertional angina 
Previous infarction 
Previous CARG 
Diabetes 
I~ypei~:holcsterolemia 
-- 
77% 11% 1.0 
8% 8% 1.0 
15% 15% 1.0 
38 48 0.11 
25% 1.8% WI 
0 0 1.0 
6% Y% 0.33 
24% 23% 0.10 
Data presented are mean value C SD or percent of patient group. CABG = 
coronary artery bypass grafting; LA5 = left anterior descending coronary artey:; 
LCx = lcfl circumflex coronary arkry; RCA = right coronq artcry. 
were performed by using the paired Student t test. SeIected 
angiographic variables were evaluated by univariate regression 
analysis for their corre!ation with absolute lumen loss and 
minima1 lumen diameter at follow-up. Multivariate srepwise 
regression analysis using a commercially available statistical 
software package (SAS, SAS Institute Inc.) was utilized to take 
into accouplt the iz&uecce of lesion jocation: preprocedural 
minimal lumen diameter, acute lumen gain and vessel size in 
evaluating their contribution to the minimal lumen diameter at 
follow-up and late lumen loss. Differences between categoric 
variables were tested with the &i-square and Fisher exact tests 
as appropriate. Target lesion r~vascular~~atior~ was anaIyzed by 
means of Kaplan-lMeie.r surviva! curves, with differences be- 
tween the two groups compared by Wilcoxon test. Ditfrrences 
were considered statistically significant where the p value was 
<0.05. 
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‘VahIe Z, Comparison of Quantitative Angiographic Data of 2% 
Matched Patients Who Underwent Atherectumy or Stem 
Implantation for Similar 1,esion Severity 
--. - -- 
Athereclomy stenting 
(0 = ii7) ($1 = 117) p Value ----Ix- ~- 
Reftxnce diern&cr pm (mnt) 3.09 2 0.45 3.111 2 0.114 O,?ll 
ivfinimal hen &mete; (mm) 
l’re I.12 i: 0.29 1.12 2 0.27 0.41 
Post .-L. - 7 “7 j’ (]A1 2.53 2: 11.37 o.!a I 
FdlOW-llp I,66 2: 0.55 196 2 0.5 I o.Lw I 
Diameter stenosis (%) 
Pre 642Y 64 2 6 0.0001 
Post 28 i: 10 ~ 21 Z-7 0.0001 
Follow-up 44 rt 17 35 i 13 0.0001 
Lumen loss (mm) 
Absolute 0.66 + 0 58 0.57 -t 0.47 0.22 
Relative 0.22 If- 0.19 0.19 + 0.15 U.18 
Restcnosis rate (96) 36 14 0.l ‘15 
Lesion length (mm) 6.83 rt 2.54 7.23 -!: 2.05 OS? 
Curvature value pre 14.5 rt 6.3 14.7 + 5.9 0.9’ 
Synnnelry index prc 0.45 t 0.25 0.37 + 0.25 0.79 
Area plaque pre (mm~) 9.53 t 4.64 9.46 t 4.00 0.8:~ 
_l___--- 
Data prese~eii are mean value i SD. Post = after intervention; pre = 
before intervention. 
minimal lumen diameter (1.12 F 0.29 mm vs. 1.12 ct 0.27 mm) 
and percent diameter stenosis (64 +- 8% vs. 64 5 So/o), 
respectively, 
fmmcdiate mid tate outcme after matching for baseline 
characteristics (Tables 2 and 3, Fig. 1). The reference diam- 
eters were not significantly different after atherectomy or 
stenting (3.23 t 0.46 vs. 3.22 t 0.41 mm, p = 9.83). Directional 
atherectomy resulted in a smakr immediate gain in minimal 
lumen diameter than did coronary stenting (‘I.20 + 0.46 vs. 
1.4.1 4 0.39 mm, p = 0.002) with a consequently lower 
postprocedural minimal lumen diameter (2.32 ri: 0.49 mm vs. 
2.53 rl: 0.37 mm, TV < 0.001) and c~n~~~nitalltly higher percent 
diameter srertosis (ZS I!L 70% vs. 21 ri: 7%, p < 0.00:). Ekuuse 
absolute loss du&g follow-up did not ditkr significantly 
between the athercctomy and stent groups (0,66 + 0.58 vs. 
0.57 + 0.53 mm, p = 0.22), the initial favorable immediate 
resu!t after stenting was maintained during follow-up. Thus, 
the minimal lumen diameter at follow-up after atherectcrmy 
was slg~ificantty Eower than after stenting (I.66 t 0.55 vs. 
1,Yd t 0.51 mm, p < 0.0001). Accordingly, atheradomy 
g- 
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Figure 1. Cumulative (CUM.) frequency curves illustrate the imme- 
diate (A) and follow-up (F-UP) (B) effects on minimal lumen diameter 
(MI,D) of directional coronary atheredomy (DCA) and stent implan- 
tation in patients matched for lesion location and severity (n = 117 
pairs). As shown, the mateking process was adequate, with supcrim- 
position of the distribution frequency curves of the minimal lumen 
diameter before atherectomy and stenting indicating similar prepro- 
cedural stenosis severity. POST = after the procedure; PRE = before 
the procedure; RR = restenosis rate (diameter stenosis at follow-up 
<5&X). 
yielded a lower net gain (0.54 t 0% vs. 0.54 t 0.53, p < 
0.0001) and a higher percent diameter stenosis at follow-up 
(44 ?I 16% vs. 35 I 13%, p < O.OOOl). The rester&s rate 
(diameter stenosis at follow-up >50%) after stenting was 
significantly lower than after atherectomy (14% vs. 36%: p = 
0.0053). These results were also found in the subgroup analysis 
for o~rk~~~~ treated patients (minimal hmen diameter 
3.2.75 mm, n = 1% paks). Although there was a trend for a 
higher postprocedural minimal lumen diattleter afkr atherec- 
tomy than after stenting (2.96 i- 0.17 G. 3.74 X!I O.‘J5 mm, p = 
0.03) in these patients, late loss was near& two times higher in 
the atherectomy group (1.03 t 0.59 vs. 0.58 t 0.6i mm, p = 
0.04), yielding a lower, but not significantly digerent, final 
minimal lumen diameter in the patients with atherectomy than 
in Ihose with stenting (1.93 t 0.55 vs. 2.16 t 0.53 mm, p = 
0.22). 
The late ciirkal follow-up was ako more favorable for 
patients with stentina and shx~wed a reduced need for repcat 
rcvwarlari2arir,17. Ctiuicai follow-up dam were available in 
Xl’% of the patieats. No deaths were observed and signifi- 
cant& fewer pa&n& with stenting than patients with atherec- 
tomy required target lesion revascularizdion (12% vs. 23% 
p = 0.1X) (Fig. 2). In multivariate analysis. lesion iocation, 
vessel size, minimal lumen diameter before inrervention, ab- 
sohrtc gain and type of ~~te~~~~~~t~~~~~l device were identlficd as 
indepuxkM prediciors of ?he absoiute lumen loss and minimai 
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Figure 2. Cumulative curves for target lesion revascularization (repeat 
angioplasty or coronary arteiy bypass surgery). Fewer patients in the 
stent group than in the atherectomy group needed revascularization of 
the target artery (p = 0.05). Abbreviations as in Figure 1. 
lumen diameter at follow-up. Both models can be described by 
the following equations: 
Ahsdute 10s~ = -0.35 - 0.24 vessel size + 0~53 gain 
+ 0.58 MLD pre i 0.16 LAD + 0.22 davic:. 
Minimal lumen diameter at follow-up == 0.35 + 0.24 vessel size 
+ 0.37 gain + 0.42 MLD pre - 0.16 L,\D - 0.22 &vice, 121 
where LAD = left anterior descending coronary artery lesion, 
MLD pre = minimal lumen diameter before the procedure; 
atherectomy = 1 and stenting = 0, LAD lesion = 1, non-LAD 
lesion = 0. 
A linear relation was observed between immediate gain and 
late loss in the two groups, with a steeper gain/loss regression 
line slope in the atherectomy group (0.50) ihan in the stent 
group (0.30) (p = NS). 
Immediate and Bate outcome after matching for both 
procedural outcome and baseline c~~a~a~te~~st~~s (Table 4, Fig. 
3). Matching for procedural outcome as well as lesion location 
and vessel size and lesion severity and procedural outcome 
identified 75 pairs of matched patients with successful atberec- 
tomy or stenting. Sy virtue of this matching protocol, vessel 
size and minimal lumen diameter before and after the proce- 
dure in the atherectomy and stent groups were similar (3.06 Z! 
(1.43 vs. 3.05 2 0.42 mm, p = 0.93; 1.09 2 0.25 vs. I.08 It 
0.24 mm, p = 0.98; and 2.41 ? 0.29 vs. 2.42 i: 0.28 mm? p = 
0.54), respectively. Therefore, the values for immediate lumen 
gain achieved with atherectomy and stenting were comparable 
(1.33 2 0.37 vs. 1.34 + 0.34 mm, p = 0,36). Patients in the 
ath~trectomy group had a signifkmily greater late loss during 
follow-up (0.75 i 0.57 vs. 01.52 -t- Od4 mm, p <C OBOG) so that 
the residual minimal lumen diameter at follow-up was signifi- 
cantly smlier al& a~~lere~to~~y than afi-er stentisg (l.fX t 
053 vs, l.ilD ri CL.47 mm, p i 0.004), Likewise, atherectomy 
yielded a higher percent diameter stenosis at follo\p-up (43 ? 
1% vs. 36 :k 12%, p < 0.004”. AdditionallyT the resfcnosis rate 
(diameter stenosis at foflo~up x%%) after stenting was 
significantly lower than after atherecmmy (12% vs. 32%, p = 
0.~~26)‘ 
Table 4. Comparison of Quantitative Angiographic Data of 150 
Matched Patients Who Underwent Atherectomy or Srent 
Implantation for Similar Lesion Scvcrity and Procedural Outcctme 
Kefbwx diamctcr pre (mm) 
Minimal lumen diiuncter (mmJ 
Prc 
PusI 
Follow-up 
Diameter stwosis (%) 
PX 
POSl 
Foilow-up 
Lumen loss (mm) 
Absolute 
Ksiativr 
Kestenosis rate (96) 
Lesion length (mm) 
Cmvatur; va!ue pre 
Symmetry index prc 
Arca plaque pre (111111~) 
Alhcrcctomy Slcntiag 
(I1 = 75) (I1 =y 75) ---l------_I”-~ 
3.06 2 0.33 3.05 rt 0.42 
f.(W t 0.25 1.05 t 0.24 
2.41 f 0.29 2.42 i: 0.28 
165 _i 0.53 1.90 2 0.47 
6428 64 I 7 
25 t 7 22 t ? 
43 rt 17 36 2. 12 
0.75 1’ 0.57 052 1 0.44 
0.3 f 0.18 0.1s i 0.14 
32 12 
6.88 2 2.34 7.40 :t 2.24 
16.5 f 6.4 Ii.7 :k 5,7 
0.4 t i 0.25 0.36 I 0.23 
“I 63 _. _ 2 4.62 9.70 :!Y 4.24 
Absolute loss = -0.74 - 0.18 vessel size + 0.68 gain 
i- 0.76 MLD pre i 0.13 LAD + 0.24 device. 
Minimal lumen diameter at follow-up = 0.75 t 0.17 vessel size 
i 11.32 gain -I 0.27 MLD pre - 0.13 LAD - 0.24 device, I4 
where MLD pre = minimal lumen diameter bcforc the 
procedure, LAD = left anterior descending coronary artebg 
lesion, atherectomy = I and stenting = 0, INI lesion = 1, 
non-LAD lesion = 0. 
After matching for procedural outcome, the @eater Ioss 
observed after directional atherectomy is reflected by the 
finding in multivariate analysis of a significant kldepcrrdent 
effect of the procedure used, whereby less late loss md g~~tcr 
minimal lumen diameter at follow-up is predicted for stent 
~~~~~lantatioll. 
In this sturdy. v:e compared the ~med~ate and long-term 
clinical and ang~ogra~hic e&x& of succcssfu1 directional 
atherectomy and stant implantation for primaty coronq 
artery lesions. The major findings of this study are threefold: I ) 
IO matched patients with similar lesion 3WiSity and location? 
srcnting is associated with a significantly larger immediate 
imnen. which is preserved during foilow-up and is reflected hy 
a conco~~ital~t reduced need for target lesion revaxulariza- 
tions during the 1st 5 months: ?) when the ~r~ed~r~ x&t 
and baseline c~racteristics are matched, otent impla~t~rit~n is 
htnd tc pr-ovkk a snporior iate ar~~~ogra~h~c o~rtcomc d!rc to 
si~i~~~.uIt less ltmm renarro~i~l~ than afrer atherectomy; hind 
3) these findings may refkct n devicespecific effect CIE lumen 
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Figure 3. Graphic display of the immediate (A) and late (B) results 
after athcrectomy and stenting in patients who were matched for lesion 
location and severity and immediate gain (n = 75 pairs). As displayed, 
the matching process was adequate, with superimposition of the 
distribution frequency curves of the minimal lumen diameter before 
and after atherectomy and stenting indicaticg similar pre- and post- 
procedural stenosis severity irrespective of the device deployed. Ab- 
breviations as in Figure 1. 
renarrowing, independent of baseline characteristics or imme- 
diate procedural result. 
Matching. To overcome the limitations in design of previ- 
ous comparative interventional studies, we applied the previ- 
ously validated concept of matching (7,X,15,19,20) to the 
atherectomy and stent groups to evaluate and compare the 
effect of the interventiondl devices used on long-term angio- 
graphic and clinical outcome. In particular, the confounding 
CB’ects of unequal vcsscl size arrd immediate lumen gain, which 
have been shown to be independent predictors of restenosis 
(4,.!5,9) and which have not been controlled in such studies, are 
avoided by this matching technique. Matching for the imme- 
diate result of intervention provides zhe possibility to objec- 
tively evah&e for a specific device effect, which was not 
possible in randomized trials, becau~c the postprocedural 
results in the treatment groups were significantly ditfcrent. 
Furthermore, matching 8 study group with a reference patient 
group of similar characteristics can compensate for some of the 
limita rions of iio~~ran~lol~~ed studies such a.s population bet- 
erogeneity (Zij. However. prospective randomized trials ore 
l:radit~~~nally regarded as the method of choice for comparing 
long-term outcome of different interventional procedures be- 
cause case se!edion is potentLIly limited in such tria!~ Bespi~:e 
a p&da1 patient selection bias in matching studies, our 
atherectomy and stent patient groups had angiographic char- 
acteristics and ai! im~r~edia~~ outcome comparable to ,hose of 
patien1.s in sevcra! reported studies (,Coronary ifngioplasty 
Versus Excisional Atherectomy Trial f CAL’EAT]~ Canadian 
Coronary Atherectomy Trial [CCAT], BElgian NEtherlands 
STENT study [BENESTENT] and STent REStenosis Study 
[STRESS]) (10---13). Thus, the findings in our comparative 
study may be applicable to patients selected for stenting or 
atherectorny and may be useful ii1 pla~ming future trials. 
~eter~~n~~t~ of a fkworable Ilong-term outcome. Wheu our 
grotrp (7,8,X?f first Eta&cd the dl%:rences between reste!~is 
after atherectarny and balloon angioplasty in a matched series, 
WC not oniy ohselved a linear relation between immediate gain 
and late loss but also recognized that the slope of this 
regression line may represent an index of lumen renarrowing 
specific for each treatment modality. In a subsequent matching 
study (20), we further extended this observation and could 
indeed demonstrate that the process of lumen renarrowing was 
dependent not only on the extent but also on the mechanism of 
lumen improvement. These observations may implicate that a 
beneficial late outcome can be achieved by using a device that 
can associate a large immediate gain with a favorable relation 
between the degree of vessel wall injury and vessel wall 
response. In the present study, we compared the two available 
interventional devices that can consistently achieve a large 
immediate gain and found that the long-term outcome after 
stent implantation is significantly superior to that after atherec- 
romy. A superior immediate gain achieved by stenting in 
patients matched only for baseline characteristics indicates 
that the improved angiographic outcome of stenting may be 
due to the combination of the extent and possibly the mecha- 
nism of lumen increase. 
Wky might denting be superior to atherectomy? The 
comprehensive analysis of long-term outcome of stent implan- 
tation and atherectomy suggests that the scaffolding effect of 
stenting may lead to less lumen loss and a larger late lumen at 
follow-up than are achieved with the debulking mechanism of 
directional atherectomy in matched patients. Multivariate 
analysis confirmed the significant independent influence of the 
device used whereby less late loss and a larger lumen diameter 
at follow-up was predicted for stent implantation compared 
with directional atherectomy. In a well-controlled serial IVUS 
study, Mintz et al. (23) found a significant difference in the 
ultrasound aspect of lumen renarrowing after ditferent trans- 
catheter treatment strategies. In particular, stented lesions 
exhibited virtually no geometric remodeling but restenosis 
consisted predominantly of intimal hyperplasia, x?le;eas re- 
madding appeared to be the main mechanism of restenosis in 
nonstented lesions. In fact, their study suggests a device- 
specific effect on restcnosis with less arterial recoil after 
slenting rhar~ after other interventirma. Kimura et ai. (personal 
c~ntn~~~~~ic~~tionj subsequoil!y do!cumented the tinx come 
after stenting and athcrectomy by using serial ultrasound 
n~~asurern~nts~ They also found a dltfercnt interrelation be- 
tween remodeling and hyper&sia in that stenting was not 
associated with immediate or late recoil whereas patients with 
atberecttrmy exhibited a geometric remodeling process (de- 
crew 21 dud alasiic fiisnbranej that WAS already present 
at ! mooth crf ~~l~~~~v-~~ and ongoing a?. 5 months, These 
LlItIast7ullcl observations support our iti%4 and suggest that a 
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lower restenosis rate after stenting may be the result of less 
vascular recoil. Indeed, earlier observational angiographic 
studies have demonstrated that this beneficial effect may be 
secondary to less elastic recoil (2~) or to the restoration of the 
“Glagovian balance” between plaque and lumen area (25). 
Furthermore, by using coronary angioscopy and ultrasound 
techniques, Baptista et al, (26) demonstrated that, compared 
with athcrectomy, stenting reduces the amount of trauma to 
the vessel wall, which ultimately may lead to a reduced vessel 
wall healing response (i.e., renarrowing). 
Therefore, the favorable stent effect found in our study 
concurs with preliminary angioscopic (27,Zb) and ultrasound 
(26,29) observations and suggests a favorable relation between 
vessel wall injury (smooth circular wall configuration) and 
vessel wall healing response (reduced geometric remodeling) 
and suggests the importance of the scaffolding action of 
stenting, If larger studies confirm this observation, the clinical 
importance is that trials of restenosis prevention attempting to 
sevent the formation of intimal hyperplasia may particularly 
affect patients with stenting because intimal hyperphda may 
be the domincnt mechanism of restenosis. It seems unlikely 
that this favorable effect of stenting is attributable to a 
difference in treatment strategy (optimal stenting versus less 
optima) atherectomy) because this effect is avoided by match- 
ing for both baseline characteristics and outcome. The 
postatherectomy lumen diameter found in our series is com- 
parahle to that observed in the CCAT and CAVEAT trials 
(IO,1 1) although smaller than in the series of Kuntz et al. (1,6), 
whereas our stent results are comparable to those reported in 
the BENESTEMT, STRESS and Palmaz-Schatz Stem Study 
trials (12,13,30). Such an observation does not influence the 
conciuslons of the present study because the linear relation 
between immediate gain and late loss is maintained at all levels 
of gain, showing a favorable effect (lower slope value) for 
stenting when compared with atherectomy. 
Clinical implications, The favorable angiographic out- 
come of stenting is further underlined by a significant reduc- 
tion in the clinical need for target vessel revascularization. In 
accordance with Bairn and Kuntz (31) we have refrtlined from 
using the composite “arry event” clinical end point criteria to 
compare stenting with atherectomy to avoid potentially con- 
founding factors induced by cardiac events not related to the 
type of interventional device used. By using such “filtered 
clinical end points” (31), we found an agreement between 
quantitative angiographic foilow-up and the late clinical 
course, emphasizing the need for a dual ar;nmach (angiu- 
graphic and &ricaf follow-up) in that quantitative angicgraphy 
demonstrdte$ the mechanistic explanation of the favorable 
stem results. whereas clinical followup provides the diical 
implications of this f&ting. The 14% resrenosis rate after 
suesslid sreuting 51~1rl in this stu&y is identical to the 14% 
restenosis rate of patieints with s~c~~ss~l~~ stentiug in the 
~E~~~~~~T sttldy (i-e.> successful stem ~~~~~~~~~~~~t~ou *brhout 
suba~~~te occlusion) and comparabh~ ta the ~~diogs oi the 
~~~~5~~~T If pilot phase (32). 
Summary and conclusions. In matched patients, successful 
stent implantation provides a more favorable long-term angio- 
graphic outcome with a reduction in rcstenosis rate and in 
need for subsequent revascularization compared with direc- 
tional athcrectomy. This favorable effect is related not only to 
a larger immediate gain but also to a device-specific eifcct, 
whereby less renarrowing is provoked by stent implantation for 
a given degree of immediate gain. 
Limitations of the study. Matching of prospectively col- 
lected patients is retrospective in nature and may have led to a 
selection bias such as the selection of larger vessels. Inherent to 
the purpose of this study, only patients who underwent a 
successful procedure were matched and included in this study, 
and we acknowledge that the results apply to a restricted group 
of patients who had a successful procedural outcome after 
undergoing atherectomy or stenting. 
Whether the favorable stent effect observed in this study is 
due only to a scaffolding effect or could also be due to 8 
difference in anticoagulant therapy, acute recoil or postproce- 
dural vessel wall configuration is beyond the scope of this 
study. However, various reports (33-35) have ruled out an 
effect of anticoagulation, whereas in this study the effect of 
acute recoil was minimized by the use of a meticulous ap- 
proach, as described earlier (7,20). Criticism of the ‘“subopti- 
ma1 result” in the atherectomy group may be valid in view of 
the very latest opinions that a postprocedural stenosis ~:20% 
must be achieved. However, such criticism applies equally to 
the stem group, and we believe it does not detract from the 
findings of a device-specific effect of stenting in the context of 
similar immediate results. Confirmation of these findings in the 
future among optimally treated lesions may be required. In 
fact, our data underscore the need for optimal results, espe- 
cially for atherectomy, to accommodate late lumen renarrow- 
ing. 
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of elected pairs, until eventwIly there are no eligible pirs remainifig 
so that all ptients are matched accordhg to the aforementioned 
matching criteria. 
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